MUDr. Michal Kýr, Ph.D.
Department vice-head, Department of Pediatric Oncology
Correspondence Address:
Černopolní 212/9, 662 63 Brno
Phone: | +420 532 23 4511, 4614 |
---|
Total number of publications: 96
2016
-
Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas
Cancer Biomarkers, year: 2016, volume: 17, edition: 1, DOI
-
Non-classical Microbes in Sputum from Children with Cystic Fibrosis and Their Clinical Significance – Retrospective Epidemiological Study
Year: 2016, type: Conference abstract
-
Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours-a single institution pilot study
Tumor Biology, year: 2016, volume: 37, edition: 7, DOI
-
Quantitative proteomic profiling in medulloblastoma recapitulates subgrouping based on transcriptional profiles
Year: 2016, type: Conference abstract
-
The meaning of sampling density in multiple repeat prostate biopsies
Central European Journal of Urology, year: 2016, volume: 69, edition: 4, DOI
-
Vztah likvorových hladin IL-6 ke změnám parciálního tlaku kyslíku v mozku a k rozvoji vazospazmů u pa cientů po subarachnoidálním krvácení z ruptury aneuryzmatu mozkové tepny
Česká a slovenská neurologie a neurochirurgie, year: 2016, volume: 79, edition: 5
2015
-
Capizzi methotrexate with BFM backbone without craniospinal irradiation is effective treatment for pediatric lymphoblastic lymphoma: results from 5 countries with I-BFM LL 09 protocol
Year: 2015, type: Conference abstract
-
DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines
Oncology Reports, year: 2015, volume: 33, edition: 5, DOI
-
Protein arrays as a tool for signaling pathways profiling in pediatric refractory solid tumors
Year: 2015, type: Conference abstract
-
Trefoil factor 3 as a marker of intestinal cell damage during sepsis
Open Medicine, year: 2015, volume: 10, edition: 1, DOI